Skip to main content
TipRanks
Go Ultimate75% OFF

Nevan Elam Insider Profile

18 Followers

Nevan Elam, CEO, Director at Rezolute, holds 605.50K shares in Rezolute (Ticker: RZLT), holds 1.40K shares in Nektar Therapeutics (Ticker: NKTR), holds 106.89K shares in Savara (Ticker: SVRA).

Nevan Elam's Trading History

RZLT
Rezolute
Jul 07, 2026CEO, DirectorUninformative Sell39.94K$2.35M
SVRA
Savara
Dec 11, 2025DirectorUninformative Buy―$516.26K
NKTR
Nektar Therapeutics
―SVP & Head of Pulmonary Bus―$52.89K

You May Also Like

Nevan Elam insider profile FAQ

What is the percentage of profitable transactions made by Nevan Elam?
The percentage of profitable transactions made by Nevan Elam is 100%.
What is the average return per transaction made by Nevan Elam?
The average return per transaction made by Nevan Elam is 87.30%.
What stocks does Nevan Elam hold?
Nevan Elam holds: RZLT, NKTR, SVRA stocks.
What was Nevan Elam’s latest transaction?
Nevan Elam’s latest transaction was an Uninformative Sell of $39.94K.
What was Nevan Elam's most profitable transaction?
Nevan Elam’s most profitable transaction was an Informative Buy of RZLT stock on February 28, 2024. The return on the trade was 173.40%.
What is Nevan Elam's role in Rezolute?
Nevan Elam's role in Rezolute is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.